Cytocast is a TechBio startup company pioneering the future of drug development with its revolutionary Cytocast Simulated Cell platform. We're transforming the landscape by enabling safer and smarter drug development, putting patient well-being at the forefront. By combining multi-omics data integration with advanced computational modeling, we're redefining drug development. Our platform allows us to predict how different drugs will affect cellular processes, making drug side effect predictions in the early phases of drug development a reality. Our focus extends to the future of personalized medicine. We're advancing beyond one-size-fits-all treatments, embracing tailored therapies powered by advanced technologies to revolutionize drug development.